On the other hand, the NAD+-consuming enzyme CD38 responsible for the decline in NAD+ levels impaired cytotoxic CD8+ T cell responses and increased propensity to infections in patients with systemic lupus erythematosus (SLE) [125]. The gene discussed is CD8A; the disease is systemic lupus erythematosus.